Publications by authors named "Stephane Nancey"

Claim this Profile
P
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.
Nicolas Mathieu, Marianne Hupé, Frédéric Heluwaert, Pauline Rivière, Xavier Hébuterne, Stéphane Nancey

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPACT OF ENDOMETRIOSIS ON THE PROGRESSION OF INFLAMMATORY BOWEL DISEASES: A MULTICENTER RETROSPECTIVE STUDY.
Lucas Guillo, Oumaya El Oumami, Philippe Seksik, Guillaume Le Cosquer, Louise Méheut, Stéphane Nancey

Clin Transl Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care for peripheral intravenous catheter: an audit in two French university hospitals.
Sophie Gardes, Alexandra Pandini, Karim Tazarourte, Céline Liard, Florian Deschamps, Stephane Nancey

Eur J Clin Microbiol Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study.
Guillaume Le Cosquer, Julien Kirchgesner, Cyrielle Gilletta De Saint Joseph, Philippe Seksik, Aurélien Amiot, Stéphane Nancey

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.
Maëva Veyssière, Nassim Hammoudi, Lionel Le Bourhis, Déborah Hassid, Joëlle Bonnet, Stéphane Nancey

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
Pauline Wils, Romain Altwegg, Anthony Buisson, Lucine Vuitton, Stephane Nancey

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Mathilde Osty, Romain Altwegg, Mélanie Serrero, Alban Benezech, Albane Lecomte, Stéphane Nancey

Aliment Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.
Marie André, Julien Kirchgesner, David Laharie, Lucas Guillo, Philippe Seksik, Stéphane Nancey

Am J Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Characterisation of Circulating Torque Teno Virus DNA Load in Crohn's Disease Patients.
Margaux Goens, William Mouton, Guy Oriol, Valérie Cheynet, Lioara Restier, Stéphane Nancey

J Med Virol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis.
Sailish Honap, Joelle St-Pierre, Michael Colwill, Kamal Patel, Catherine Le Berre, Stephane Nancey

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.
Xavier Roblin, Sophie Vieujean, Stéphane Nancey, Xavier Hebuterne, Nadia Arab-Hocine

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.
Uria Shani, Monica State, Radu Bogdan Mateescu, Ana-Maria Davidoiu, Lucian Negreanu, Stephane Nancey

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus Kinase (JAK) Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study.
Sailish Honap, Maria José Temido, Eathar Shakweh, Fakhirah Badrulhisham, Natalie Shields, Stephane Nancey

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Understanding Intestinal Homeostasis: Lessons from Inflammatory Bowel Disease and Monogenic Intestinal Disorder Pathogenesis.
Céline Petit, Aurore Rozières, Gilles Boschetti, Christophe Viret, Mathias Faure, Stéphane Nancey

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.
Idan Goren, Ortal Fallek Boldes, Tomer Boldes, Oleg Knyazev, Anna Kagramanova, Stéphane Nancey

J Crohns Colitis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Sexual Quality of Life Score for Youths With Inflammatory Bowel Disease.
Alexandre Mancheron, Agnès Dumas, Isabelle Nion Larmurier, Cecilia Landman, Laurent Peyrin Biroulet, Stéphane Nancey

J Crohns Colitis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.
Nicolas Richard, Aurélien Amiot, Philippe Seksik, Romain Altwegg, David Laharie, Stéphane Nancey

Aliment Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort.
Catherine Reenaers, Diana Enea, Marie Nachury, David Laharie, Yoram Bouhnik, Stéphane Nancey

J Crohns Colitis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Autophagy, dendritic cells, and Crohn's disease - "There is no point in running ; we must leave at the right time"].
Leslie Andromaque, Stéphane Nancey, Mathias Faure, Aurore Rozières

Med Sci (Paris)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study).
David Laharie, Yoram Bouhnik, Lucine Vuitton, Amélie Biron, Gaelle Pierron, Stephane Nancey

Clin Res Hepatol Gastroenterol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study.
Guillaume Bouguen, Laure Gossec, Vered Abitbol, Eric Senbel, Guillaume Bonnaud, Stéphane Nancey

BioDrugs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
Maria Alonso-Gomez, Anne Laure Charlois, Eddy Cotte, Claire Gay, Pauline Danion, Stéphane Nancey

Clin Res Hepatol Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety comparison of single-donor and pooled fecal microbiota transfer product preparation in ulcerative colitis: systematic review and meta-analysis.
Bastien Laperrousaz, Benoît Levast, Mathieu Fontaine, Stéphane Nancey, Pierre Dechelotte

BMC Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring in inflammatory bowel disease: recent developments.
Xavier Roblin, Robert D Little, Nicolas Mathieu, Stephane Paul, Stephane Nancey

Expert Rev Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.
Bénédicte Caron, Philippe Seksik, Anthony Buisson, Pauline Wils, Guillaume Savoye, Stephane Nancey

Therap Adv Gastroenterol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis